SecBot SecBot
8-K ·Filed Nov 2, 2026

TXG

10x Genomics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed14d 6h ago SEC0001628280-26-068867
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

Monitor for any strategic shifts given Satpathy's AI/drug discovery background and Gilliam's med-tech operational experience, but no immediate financial impact expected.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$65.29
T+0 close · Nov 2, 2026 · via day close
Latest settled
−3.66%
T+5 · $62.90 · next T+20 in 15d
Vs SPY
−3.07%
α at T+5
Latest observation
−10.01%
T+8 · FF3 residual α
  1. T+0 · Nov 3 $65.29entry
  2. T+1 · 13d ago +3.42%α +1.76% · $67.52
  3. T+5 · 7d ago −3.66%α −3.07% · $62.90
  4. T+9 · todayOpen
  5. T+20 · in 15d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

10x Genomics appointed Ansuman Satpathy, a Stanford professor and venture partner, and Joseph Gilliam, President/COO of Glaukos Corporation, to its Board of Directors as Class III directors effective October 28, 2026. Gilliam was also appointed Chair of the Audit Committee. This is a routine board expansion with no departure of existing officers.

Key Facts

  • Ansuman Satpathy and Joseph Gilliam appointed to the Board of Directors as Class III directors effective October 28, 2026.
  • Satpathy is an Associate Professor at Stanford and a venture partner at Wing Venture Capital; Gilliam is President/COO of Glaukos Corporation.
  • Joseph Gilliam appointed Chair of the Audit Committee on October 30, 2026, with an additional annual retainer of $25,000.
  • Each new director receives standard non-employee director compensation: $60,000 annual cash retainer, a one-time RSU grant of $400,000, and annual RSU grants of $215,000.
  • Satpathy's prior scientific advisor agreement (10,000 RSUs) was terminated in October 2026 upon his board appointment.

Financial Impact

Standard non-employee director compensation: $60,000 annual cash retainer plus RSU grants valued at $400,000 (one-time) and $215,000 (annual) per director.

compensation expense

Risk Factors

  • No material risks identified; routine board appointment.

Market Snapshot

Exchange
Nasdaq
Sector
Laboratory Analytical Instruments
Analyst Consensus
45% bullish (22 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001628280-26-068867
Document: 0001628280-26-068867-index-headers.html0001628280-26-068867
Document: 0001628280-26-068867-index.html0001628280-26-068867
Document: 0001628280-26-068867.txt0001628280-26-068867

Track record

28 reports on TXG

Performance horizon

1 of 6 bullish or bearish reports moved the stock their way by T+60. Best: +8.89% at T+60 after the Aug 19, 2026 report. 2 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $55.40 Now $54.99 −0.74% settles Feb 12
  2. Nov 6, 202610d ago 3 Neutral 1/10 Entry $65.05 Now $54.99 −15.47% settles Feb 5
  3. Nov 6, 202610d ago 3 Neutral 1/10 Entry $65.05 Now $54.99 −15.47% settles Feb 5
  4. Nov 5, 202611d ago 8-K Bullish 6/10 No price data
  5. Nov 5, 202611d ago Press Release Mixed 5/10 Entry $59.28 Now $54.99 −7.24% settles Feb 4
  6. Nov 2, 202614d ago 8-K Neutral 2/10 Viewing Entry $65.29 Now $54.99 −15.78% settles Feb 1
  7. Oct 23, 202624d ago Institutional Cluster Neutral 2/10 Entry $71.55 Now $54.99 −23.14% settles Jan 21
  8. Oct 7, 20265w ago SC 13G/A Neutral 2/10 Entry $77.28 Now $54.99 −28.84% settles Jan 5
  9. Sep 24, 20267w ago Insider Cluster Neutral 3/10 Entry $85.71 Now $54.99 −35.84% settles Dec 21
  10. Sep 22, 20267w ago 144 Neutral 2/10 Entry $75.62 Now $54.99 −27.28% settles Dec 17
Showing 10 of 28

US Market Status

Market Closed · Opens Wed (10h 33m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 2, 2026